Join Fred Hutch for the Gastrointestinal Cancers Symposium where leading experts will share latest advances in research, treatment, and patient care. The program will feature sessions on esophageal and gastric cancers, pancreatic cancer, hepatobiliary cancers, neuroendocrine neoplasms and colorectal cancers.
The symposium is intended for oncologists, advanced practice providers, surgeons, gastroenterologists, radiation oncologists, nurses, and allied healthcare professionals.
Accreditation:
In support of improving patient care, the University of Washington School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Washington School of Medicine designates this live activity for a maximum of 5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Objectives:
- Identify cutting-edge local therapy approaches for the management of GI cancers
- Describe the role of molecular testing in the management of GI cancers, including different platforms, components, and applications
- Summarize novel systemic therapy approaches for the management of GI cancers, such as opportunities for targeted therapy and immunotherapy
- Review the changing epidemiology of colorectal cancer, including the rising incidence in younger adults, factors associated with disease development, as well as health disparities and unintended biases affecting outcomes of patients with colorectal cancer
This event is open to all oncology healthcare professionals.
Registration closes on Friday, April 2, 2027 at noon PT.